Kara A Lombardo Selected Research

Hyperplasia

1/2018

Retrospective Analysis of Atypical Glands Suspicious for Carcinoma in Transurethral Resection of Prostate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kara A Lombardo Research Topics

Disease

11	Neoplasms (Cancer) 05/2024 - 01/2016
8	Carcinoma (Carcinomatosis) 01/2024 - 01/2018
4	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 01/2022
3	Bites and Stings (Sting) 12/2023 - 01/2022
2	Virus Diseases (Viral Diseases) 10/2023 - 03/2022
2	Carcinoma in Situ 01/2021 - 01/2019
2	Small Cell Carcinoma 01/2021 - 02/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2017
2	Adenocarcinoma 07/2018 - 01/2017
2	Eosinophilic Esophagitis 01/2018 - 10/2017
1	Pneumonia (Pneumonitis) 03/2022
1	COVID-19 03/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 10/2018
1	Atrophy 01/2018
1	Hyperplasia 01/2018
1	Gender Dysphoria 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2017
1	Inflammation (Inflammations) 10/2017
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 10/2017
1	Ulcer 01/2017
1	Genetic Translocation (Chromosomal Translocation) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Adenocarcinoma of Lung 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 03/2022 - 10/2017
2	cyclic diadenosine phosphateIBA 12/2023 - 01/2022
2	Pathogen-Associated Molecular Pattern MoleculesIBA 12/2023 - 01/2022
2	VaccinesIBA 10/2023 - 03/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	InterferonsIBA 01/2022 - 01/2022
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 10/2017
1	JHU083IBA 05/2024
1	ProdrugsIBA 05/2024
1	Glutamine (L-Glutamine)FDA Link 05/2024
1	CarcinogensIBA 01/2022
1	enfortumab vedotinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Fumarate Hydratase (Fumarase)IBA 01/2021
1	trastuzumab deruxtecanIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 02/2020
1	prosteinIBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 01/2019
1	Coloring Agents (Dyes)IBA 10/2018
1	HLA-A Antigens (HLA-A)IBA 10/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 07/2018
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2018
1	Chemotactic FactorsIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2017
1	Anaplastic Lymphoma KinaseIBA 01/2016
1	ceritinibIBA 01/2016

Therapy/Procedure

5	Therapeutics 01/2022 - 10/2017
2	Neoadjuvant Therapy 01/2024 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2024
1	Radiotherapy 01/2022
1	Transurethral Resection of Bladder 02/2020
1	Cystectomy 02/2020
1	Sex Reassignment Surgery 01/2018
1	Transurethral Resection of Prostate (TURP) 01/2018
1	Cautery 01/2018
1	Chemoradiotherapy 01/2017
1	Cytoreduction Surgical Procedures 01/2017